brelovitug
·Code: BJT-778
brelovitug: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | Phase 3 |
Clinical Trials (1)
A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Frequently asked questions
Who is developing brelovitug?
brelovitug is being developed by Mirum Pharmaceuticals, Inc..
How many clinical trials involve brelovitug?
BioSniper tracks 1 clinical trial involving brelovitug.
Get deeper analysis on brelovitug
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis